This share rocketed recently – do I think you should buy now?

Does a rising share price make this share a compelling buy with future potential or is it overvalued?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Jupiter Fund Management (LSE: JUP) is an active asset manager and with the rise of passive investment funds such as those from Legal & General, it’s understandable why investors may be concerned about the prospects for a company like Jupiter. Certainly, the shares until recently had been struggling, over five years they are still down nearly 11% despite a recent rebound. So far this year the share price is up 26.5%, with much of the impetus coming after recent full-year results. 

Why did the shares rocket?

The results released last week weren’t overwhelmingly positive, but despite that, the shares surged. Why was that when the full-year profit, assets under management (AuM), and even the dividend fell? Could it be that canny investors have spotted something the rest of us missed and does that mean we should all be piling in?

It was the fact the dividend was still higher than expected that seemingly pleased investors. That hardly sounds like a business in great shape or worthy of being part of an investor’s portfolio – at least from my point of view. It’s difficult to recommend investing in a shrinking business, thereby reducing the safety margin for any new investor. And it’s even harder to recommend it when the share price is going up.

The company’s results showed in the year to the end of December 2018, pre-tax profit fell by £13.7m to £179.2m as assets under management declined 15% to £42.7bn amid net outflows of £4.6bn.

The last update before the full-year’s results showed that in there were £1.5bn of net outflows in the last quarter of 2018 as weak markets led to £5bn fall in assets under management to £42.7bn. The largest proportion of the business, mutual funds, was the hardest hit as well, which doesn’t bode well for a future recovery in the business.

This is especially the case given that the results for the year ended December 2017 were much brighter – so the firm has been seeing a marked deterioration in performance in the last 12 months. In 2017, profit before tax increased 13% to £192.9m and total dividends per share of 32.6p, an increase of 20%. 

What should an investor do?

Overall, this confusing position – where the company is making less profit but has a rapidly rising share price – doesn’t to me make it a good investment case. I don’t see how now it could possibly be the time to buy the shares, despite a fairly low P/E of 12 and a dividend yield which is over 4.5%. Signs of an improvement at Jupiter under the leadership of a new CEO, Andrew Formica, may change my opinion, but evidence for that currently doesn’t exist.

It’ll be interesting to see what the new CEO intends to do with Jupiter to stem the amount of money leaving the business and how it positions itself against passive funds. Ironically, in the same week as Jupiter said it was shrinking, rival Legal & General became the first UK £1trn fund manager – showing investors are keen to invest – just not with Jupiter.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Andy Ross has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »